Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TERBUTALINE Cause Interstitial lung disease? 30 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 30 reports of Interstitial lung disease have been filed in association with TERBUTALINE (Terbutaline Sulfate). This represents 1.8% of all adverse event reports for TERBUTALINE.

30
Reports of Interstitial lung disease with TERBUTALINE
1.8%
of all TERBUTALINE reports
13
Deaths
17
Hospitalizations

How Dangerous Is Interstitial lung disease From TERBUTALINE?

Of the 30 reports, 13 (43.3%) resulted in death, 17 (56.7%) required hospitalization, and 14 (46.7%) were considered life-threatening.

Is Interstitial lung disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TERBUTALINE. However, 30 reports have been filed with the FAERS database.

What Other Side Effects Does TERBUTALINE Cause?

Dyspnoea (404) Asthma (371) Wheezing (265) Loss of personal independence in daily activities (186) Therapeutic product effect incomplete (168) Sleep disorder due to a general medical condition (149) Drug ineffective (148) Cough (138) Pneumonia (128) Full blood count abnormal (103)

What Other Drugs Cause Interstitial lung disease?

METHOTREXATE (3,049) RITUXIMAB (2,458) PEMBROLIZUMAB (2,113) PREDNISONE (1,850) CYCLOPHOSPHAMIDE (1,725) NIVOLUMAB (1,538) AMIODARONE (1,421) DOXORUBICIN (1,352) ETANERCEPT (1,267) ADALIMUMAB (1,250)

Which TERBUTALINE Alternatives Have Lower Interstitial lung disease Risk?

TERBUTALINE vs TERCONAZOLE TERBUTALINE vs TERIFLUNOMIDE TERBUTALINE vs TERIPARATIDE TERBUTALINE vs TERIZIDONE TERBUTALINE vs TERLIPRESSIN

Related Pages

TERBUTALINE Full Profile All Interstitial lung disease Reports All Drugs Causing Interstitial lung disease TERBUTALINE Demographics